Posterior capsule opacification is the main complication of cataract surgery. Using adenovirus-mediated gene transfer, we recently reported that it was feasible to prevent PCO by overexpressing pro-apoptotic molecules such as procaspase 3 or Bax in the residual lens epithelial cells postcataract surgery. However, this approach is feasible only if gene transfer can be restricted to the residual cells responsible for PCO. Initially, we tested an adenovirus (human serotype 5, HAd5), a lentivirus (HIV) and an oncoretrovirus (MLV) vector for the their in vivo transduction efficiency of rabbit lens cells. We found that HAd5 vectors were the most efficient (490% of the cells could be transduced). Six potential lens-specific promoters were then cloned into HAd5 vectors and assayed for their ability to target expression to a specific population of cells, using in vitro, ex vivo and in vivo rabbit tissues and human lens capsular bags. We found that the LEP503, MIP and Filensin promoters induced strong lensspecific expression of a reporter gene, in human lens cells. Following this ex vivo assay, we showed in a rabbit PCO model that gene transfer could be spatially restricted to the capsular bag by confining the vector with Matrigel. Our combined approach using a lens-specific promoter and a biocompatible gel should render feasible a novel therapeutic strategy for PCO that targets the remaining lens cells.
Introduction
Cataract, caused by opacification of the lens, is an extremely frequent illness developing inexorably with age. It has a major repercussion on visual functions. The only treatment consists in lens extraction with conservation of its envelope, the capsular bag (phacoemulsification). Improvements of the surgical technique have substantially decreased post-operative complications. Besides, loss of accommodation, posterior capsule opacification (PCO) is the most frequent complication after cataract surgery that has not been solved yet. Posterior capsule opacification consists of clouding of the remaining lens capsular bag causing a renewed loss of visual acuity. 1 The incidence of PCO, which is B50% in adults and 100% in children, has been lowered by improved surgical techniques and improvements in the material or the design of the intraocular lens (e.g. the square edge and the twin-capsulorhexis lens). [2] [3] [4] However, while these elegant surgical approaches have greatly diminished the incidence of PCO, they have not yet completely eradicated it. The development of an alternative therapy for preventing PCO is of critical importance since YAG laser treatment of PCO can lead to severe complications such as retinal detachment and macular edema. Furthermore, the importance of preventing PCO has been increased by the recent potential development of surgical procedures for presbyopia that can only be implemented if the capsule remains clear. As PCO results from the proliferation of residual lens epithelial cells remaining in the capsular bag postsurgery, 5 we proposed to eradicate these cells by introducing a cytotoxic gene in the capsular bag. This approach is capable of eliminating the cells post-cataract surgery, while respecting the surrounding ocular tissues. Using a rabbit model of PCO, we demonstrated the efficacy of this in situ gene transfer approach using herpes simplex virus (HSV)-thymidine kinase (TK) gene and, more recently, pro-apoptotic molecules. [6] [7] [8] However, because these gene products lead to cell death in all transduced cells, it is imperative that gene transfer is restricted to the residual lens cells.
In the present study, we assayed promoters for their ability to drive lens-specific expression of the ectopic gene. Human adenovirus type 5 (HAd5) vectors expressing b-galactosidase (b-Gal) under the transcriptional control of six lens-specific promoters were generated and tested. Ad vectors were chosen because, in our hands, they were the most efficient tools and transduced almost 495% of lens cells in vitro and in vivo. 7 In addition, to our knowledge, there is no vector integration in the genome of peripheral cells (i.e. cornea cells) that may be transduced, but not killed, by the gene transfer. The six potential lens-specific promoters used were: the human aA-crystallin promoter, 9, 10 a mutated form of this promoter, [11] [12] [13] the human gD-crystallin promoter, 14,15 the MIP promoter, [16] [17] [18] the LEP503 promoter 19, 20 and the Filensin promoter. [21] [22] [23] HAd5 vectors encoding the b-Gal gene under the transcriptional control of these promoters were used in vitro on rabbit lens cells, ex vivo on human lens capsular bags, and in vivo in a rabbit model of PCO. Our aim was to compare the efficiency of the promoters to specifically express an ectopic gene in lens cells. We found that LEP503Ad-mediated expression of b-Gal was restricted to lens cells from rabbit and human and that MIP and Filensin promoters are good candidates for restricting an ectopic gene expression in human lens cells. Finally, to limit the biodistribution, we tested different biocompatible gels to sequester the viral vector in the capsular bag. Combining the biopolymer gel's ability to release the vector 'in situ' and a lens specific promoter could allow a specific expression of a transduced ectopic gene in residual lens cells after PCO.
Results

Comparison between dividing cells targeting vectors and adenovirus vector
Numerous gene transfer platforms exist, and each has its collection of advantages and disadvantages. For PCO therapy, we believe that high-titred vectors with rapid transgene expression would be the most characteristics. Therefore, to select an efficient vehicle for gene transfer, we compared the transduction efficiency of residual lens cells using three viral vectors: (i) a HAd5 DE1/E3; (ii) a VSV-G envelope pseudo-typed oncoretrovirus (murine leukaemia virus, MLV) able to target dividing cells; and (iii) a third-generation lentiviral (HIV) also pseudo-typed with a VSV-G envelope. We found that the MLV vector was the least efficient, with B10% of the residual lens cells that were transduced. Although the HIV vector can efficiently transduce dividing and non-dividing cells, in this scenario it was less efficient than the HAd5 vector, which transduced 495% of residual lens cells (Figure 1 ).
Detection of lens cells-specific mRNAs and proteins
To be clinically relevant for PCO therapy, ectopic transgene expression needs to be confined to the target cells, particularly when a cytotoxic gene is expressed. One way of confining expression is using a tissue-specific promoter. A number of genes with a lens-specific or lensrestricted expression pattern have been described. As most of these studies have used rodents, we selected five genes (aA-crystallin, gD-crystallin, MIP, LEP503 and Filensin) and tested their expression ex vivo in human lens and other parts of the eye. We performed reverse transcriptase-polymerase chain reaction (RT-PCR) using mRNA isolated from the different parts of human eyes (lens, cornea, retina, iris, and choroid). Using this assay, no transcripts were specific for human lens cells (Table  1) . Similar results were also obtained in rabbits (Table 1) .
Reverse transcriptase-polymerase chain reaction is a sensitive method that allows detection of only few copies of an mRNA, which supersedes the detection of the corresponding protein. Therefore, to complement the RT-PCR assay, we used immunohistochemistry to assay aA-crystallin expression in monkey eyes (Figure 2) , and found that it could only be detected in the capsular bag. Similar to the data using human and rabbit tissues, RT-PCR amplification revealed expression in the monkey iris (not shown). Lens-specific expression for gene therapy of PCO F Malecaze et al We, therefore, decided that the most appropriate way to evaluate the promoter specificity was to clone them into a HAd5 vector and to test the expression of a reporter gene. This protocol was applied in vitro, ex vivo and in vivo to assay the specificity of reporter gene expression in lens cells.
Lens-specific promoters in rabbits
The aA-crystallin, gD-crystallin, MIP, LEP503 and Filensin promoters were subcloned upstream of lacZ in HAd5 vectors. The vectors (as well as AdCMVbgal vectors) were incubated with lens cells in culture (in vitro experiments), capsular bags or corneas in organoculture (ex vivo experiments) or injected after phacoemulsification (in vivo experiments). The vectors were used at a MOI (infectious units/cell) of 100 for in vitro experiments and at a dose of 10 8 infectious units/injection for the ex vivo and in vivo experiments.
In vitro
Following incubation of the respective vectors, all of the above promoters induced the transcription of the lacZ, and therefore b-Gal activity in rabbit lens cells (Figure 3 ). The LEP503, MIP and Filensin promoters were very active, ectopic b-Gal activity was detected in virtually all cells. These data clearly demonstrated that the HAd5 vectors efficiently transduce rabbit lens cells. The aAcrystallin and gD-crystallin promoters were weaker, with only 47 and 32% of cells expressing detectable levels of b-Gal activity. To increase expression of the aA-crystallin promoter, we tested a mutated form (aA mut ) known to be stronger. The use of aA mut significantly increased the percentage of cells with b-Gal activity (B90% of cells). The aA mut LEP503, MIP and Filensin promoters thus all induced a high expression of the ectopic gene in rabbit lens cells.
Ex vivo
We then tested the vectors in an ex vivo model (rabbit capsular bags and cornea). The HAd5 vector containing the LEP503 promoter led to lens-specific expression; the 
Human tissue is to the left, rabbit tissue is to the right and in bold. 
In vivo
Finally, to assay the specificity of the promoters in vivo, we used a rabbit model of PCO. Similarly to our ex vivo experiments in the rabbit lens, the vector containing the LEP503 promoter induced lens-specific expression of b-Gal in vivo (Figure 4b ). The aA-and gD-crystallin promoters were not lens-specific; expression was also detected in other eye tissues (not shown). No b-Gal activity was detected following gene transfer with cassettes containing the MIP and Filensin promoters. Thus, we found a correlation between the results ex vivo and in vivo on the potency and the specificity of the promoters. In the context of a HAd5 vector the LEP503 promoter was the most promising, leading to lensspecific expression in rabbits ex vivo and in vivo.
Lens-specific promoters in human explants
While testing the vectors in rodent and nonhuman primate tissues is an important preclinical step, the results will not a priori translate into the same results in human tissues. To address this caveat, we analyzed the efficacy of HAd5-mediated expression of b-Gal ex vivo in human capsular bags and corneas ( Figure 5 ). In this context and similar to our above results, the aA-and gD-crystallin promoters used in this study were not lensspecific in human tissue. The promoters from the LEP503, MIP and Filensin genes led to lens-specific b-Gal activity in human tissue ex vivo.
Sequestering vectors in biocompatible gels
The specificity of the transgene expression could, in principle, be improved by sequestering the vector inside the capsular bag using a biopolymer. We hypothesized that this approach would avoid the extravasation of the vector to surrounding tissues and additionally allow direct contact with the residual lens cells in the capsular bag ( Figure 6 ). We initially performed in vitro experiments to optimize release and transduction of the vector. Using AdCMVbgal (to allow high level expression in all cells) incorporated inside the gel (Matrigelt or Figure 6 Drawing of the principle of the surgically induced specificity using a gel allowing an in situ release of the vector. The adenovirus vector containing gel is injected into the capsular bag after having removed the lens by phacoemulsification.
Lens-specific expression for gene therapy of PCO F Malecaze et al Healont), a contact of 10 min allowed a high level of transduction (Figure 7a ). Then following phacoemulsification in rabbit eyes, we injected a mix of vector and gel into the capsular bag. The vector-gel was removed 10 min later (similar to our in vitro experiments and compatible with clinical constraints). Transgene expression was poor using Healon, while Matrigel allowed a focal transduction of the residual lens cells (Figure 7b) . The low percentage of b-Gal positive corneal cells using Matrigel shows that this approach effectively limits the vector biodistribution.
Discussion
Currently there is no preventive treatment for PCO, which is the main complication of cataract surgery. We are trying to develop an alternative and preventative strategy using transient gene therapy. We previously found that post-phacoemulsification it was possible to lower the incidence of PCO by killing residual lens cells in the capsular bag. Our previous approaches used gancyclovir-induced cell death post-transduction with a HAd5 vector containing a TK expression cassette, 7 and more recently by inducing apoptosis in lens cells. 8 A potential problem with our approach is that destroying the lens epithelial cells might have an adverse effect on the integrity and transparency of the posterior region of the capsular bag. Production of the posterior capsule stops early in life and it is not clear at present to what extent the lens epithelial cells play a role in maintaining the posterior capsule (for a review, see Krag and Andreassen. 24, 25 ) On the basis of the available information, we surmize that at least in elderly patients a loss of lens epithelial cells will not lead to loss of integrity and transparency of the posterior region of the capsular bag. However, this potential complication will need to be assessed in a long-term follow-up study of animal models.
There are several potential options to target the apoptosis inducer gene products to lens cells. Our first approach was to try to target the mitotic activity of lens cells, which are the only dividing cells in the anterior segment of the eye post-surgery. In a previous report, 6 we used an MLV vector that is capable of transducing only dividing cells. This approach was unsuccessful as this vector poorly transduced a high percentage of cells or prevented PCO. We hypothesized that this inefficiency was due, in part, to the vector envelope and that by using a GalV or a VSV-G envelop the percentage of transduced cells could be improved. However, with the VSV-G pseudo-typed MLV vectors used in this study, the percentage of transduced lens cells remained low. There are probably several reasons for the low efficiency, the most probable is that only a fraction of the cells are dividing at a given time and the vector is quickly cleared from the capsular bag. Finally, while the efficiency of transduction by the lentiviral vector was better than MLV, it was still less than with HAd5 vectors. Another alternative to preferentially target lens cells is the potential use of vector that specifically transduces lens cells. However, to our knowledge, there are no lens cellspecific vectors available.
A more classic option to target apoptosis to lens cells is to direct a lens-specific transcription. Thus, we performed a screening analysis to choose the best promoter to restrict the gene expression. Crystallins are the major proteins of the lens, 26 and in mammals are encoded by three major gene families (a, b and g). 27 Unlike aB-crystallin, which is expressed in many tissues, aA-crystallin is present almost exclusively in the lens. 28 It is expressed by epithelial cells and highly expressed in the fiber cells. A g-crystallin promoter is also a potential candidate for lens-specific expression, because g-crystallins are highly and specifically expressed when the lens epithelial cell differentiate into fiber cells. Notably, the above promoters are active in early development. The induction of growth factors post-cataract surgery could cause a recapitulation of the developmental program. Promoters of other non-crystallin lens-specific genes were also potential candidates. These include the (i) major intrinsic protein (MIP), which is a membrane bound water channel protein expressed exclusively in the lens, and whose promoter is well characterized; 16 (ii) Filensin, an intermediate filament protein that is expressed throughout all stages of lens cell differentiation 21 and (iii) LEP503 (lens epithelium gene product), which has a lens epithelial cell-restricted expression. 19, 20 Our RT-PCR analysis of the expression of these selected transcripts revealed that the corresponding promoter, was not lens-specific. However, the sensitivity of PCR is high, and a low amount of mRNA might not lead to detectable levels of the corresponding protein. 
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For example, by immunohistochemistry we detect aAcrystallin exclusively in the lens, while the corresponding RT-PCR analysis detected aA-crystallin mRNA in other tissues. Thus, construction of vectors containing a reporter gene under the transcriptional control of the different promoters was used to address the question of the specificity. Two promoters stood out in the experiments conducted in rabbits. The LEP503 promoter led to the best results ex vivo and in vivo, with respect specificity and efficacy. The aA-crystallin promoter which was successfully used in transgenic mice, 9, 11, 12, 29, 30 was less efficient in our experiments. We detected only 47% of cells expressing detectable amounts of b-Gal using the aAcrystallin promoter, suggesting that this promoter led to a low transcriptional activity in lens cells. Following this, we tested the aA mut promoter. However, this promoter was not suitable for our experiments because while it increased the percentage of cells expressing b-Gal (90% of cells were transduced), it diminished the specificity. Our data using human tissue highlighted noteworthy differences with the in vivo rabbit experiments: while we observed a low level of expression of the MIP and Filensin promoters in rabbits, these two promoters were strong and specific in human capsules. These promising results in human, in contrast to rabbit tissue, are encouraging for a clinical application. Although we cannot formally exclude it, the difference in expression pattern is unlikely due to the use of human promoters in rabbit tissues. The regulatory elements of lens promoters are highly conserved. It is possible that the difference in expression profile of the promoters is due to the age of the donors of the tissues, (young rabbits versus elderly human donors): gene expression in the lens is tightly controlled during development and expression patterns change with age. Further work is required to determine the effect of developmental age of the lens cells targeted.
Our results demonstrated the efficacy of LEP503, Filensin or MIP promoters for a reporter gene expression restricted to the residual lens cells post-PCO. However, expression of the transgene in other cell types cannot be totally excluded. We tried to improve the clinical relevance and safety of this strategy by sequestering the vector in the capsular bag, creating an almost closed system. The validity of this strategy using Matrigel was encouraging due to the absence of corneal endothelial cell with b-Gal activity in the rabbit PCO model -even when we use a strong ubiquitous, constitutive viral promoter. Our combined promoter-gel specificity approach should render feasible a novel therapeutic strategy for PCO by targeting residual lens cells.
Materials and methods
Reagents
Foetal calf serum (FCS) and culture media were purchased from BioWhittaker (Emerainville, France). Lentiviral vectors have been produced after quadritransduction of 293T cells by plasmids kindly provided by D Trono (Lausanne, Switzerland). Oncoretroviral vectors were produced by tri-transfection of plasmids (pMDG and pGagpol) kindly provided by the GVPN (Genethon, Evry, France).
Reverse transcriptase-polymerase chain reaction
Total RNA was isolated from eye tissues, as described by Chomczynski and Sacchi 31 using TRIZOLt following the manufacturer's recommendations (Life Technologies, Cergy Pontoise, France). RNA solutions were treated with 5 U of DNAse 1 (Roche Diagnostics, Mannheim, Germany) to remove any contaminating genomic DNA. mRNA was transcribed into cDNA using the Ready-togot kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA) and random primers were purchased from Life Technologies. Amplification of cDNA was carried out using 1 U/100 ml of Taq DNA polymerase (Roche Diagnostics, Mannheim, D) in a PTC-100t Programmable Thermal Controller (MJ Research, Watertown, MA, USA) after 33 cycles consisting of denaturation at 941C (60 s), annealing at 651C (60 s) and elongation at 721C (120 s). The following primers were used. They were chosen in order to amplify either human or rabbit DNA because of the high homology between the two species: 5 0 -CAGAACCCCTGGTTCAAGCG and 5 0 -CCGCGAAC TCCTCCTGCACC which amplify a 248 bp cDNA corresponding to the aA-crystallin transcript; 5 0 -TCTCAC AGGATCAGACTC and 5 0 -CCACTCTGGCATTCGTGG which amplify a 235 bp cDNA corresponding to the gDcrystallin mRNA; 5 0 -CCGGACACAGCCCCTAGCC and 5 0 -GCAGTTCCTTGATACACC which amplify a 170 bp cDNA corresponding to the LEP503 mRNA; 5 0 -GTGGG AACTGCGATCAGC and 5 0 -GGTTTCCTCGGACAGCA GG which amplify a 342 bp cDNA corresponding to the MIP transcript; 5 0 -GCTGACCGGCTCTGGAAC and 5 0 -CCGCGGGCTGGGCGCGCTC which amplify a 144 bp cDNA corresponding to the Filensin mRNA. Polymerase chain reaction (PCR) products and the lambda/HindIII molecular weight marker (Promega, Lyon, France) were separated by electrophoresis on 0.8% agarose (Roche, Mannheim, Germany), Tris-Borate EDTA (Interchime, Monluçon, France) gels and visualized by staining with ethidium bromide.
Immunohistochemistry
Phacoemulsification was performed on three old world monkeys (Macaca mulata) and an immunohistochemistry of the anterior segment of the eye was performed with a polyclonal anti-aA-crystallin antibody from rabbits produced in N Lubsen's laboratory using classical immunohistochemical methods. Briefly, sections were incubated initially in a solution of 5% Bovine serum albumine in PBS for 30 min at room temperature, then incubated for 90 min with anti-aA-crystallin (1:100). Following washing, the sections were incubated with FITC (Fluoro-isothiocyanate)-conjugated goat anti-rabbit antibody (1:100) (Sigma, France) or appropriate controls for 1 h, washed twice with PBS and finally examined with a Leitz fluorescence microscope.
Construction and preparation of adenovirus vectors
The different DNA fragments corresponding to the promoters compared in these experiments data were cloned into the adenovirus plasmid (pShuttle) commercialized by Qbiogen (Illkirch, France). p708 is a plasmid containing DNA encoding b-Gal and polyA site. This plasmid was obtained by inserting a fragment HindIIIPst1 generated from the plasmid pCH110 in pBluescript polyA (HindIII-Pst1). To obtain the fragment b-Gal- The aA-crystallin promoter fragments were obtained by PCR amplification. The primers used were 5 0 -GCTCT AGATATCTGGAGGTTTCGGAGCTC and 5 0 -CCAAGC TTCCTACCGAAGGCTGGCAGTGAGTCAG. The PCR fragment was digested EcoRV and HindIII. It was inserted in pShuttle b-Gal-polyA to generate pShuttle aA-crystallinbgal-polyA. pShuttle aA mut -crystallinb-gal-polyA contains mutated form of aA-crystallin promoter, which was inserted in pShuttle b-Gal-polyA after digestion with KpnI and HindIII. The promoter of LEP503 cloned in the plasmid pGL3-Basic/H503 was a generous gift of Yi Wen (Los Angeles, CA, USA). The promoter and luciferase coding region were excised from pGL3-Basic/H503 by a Cla1 digestion. The fragment was inserted in Cla1 digested pBluescript. The LEP593 promoter fragment was then obtained by a Kpn1/EcoRV digestion and inserted in pShuttle b-Gal-polyA to obtain pShuttleLEP503b-gal-polyA. The promoter of gD-crystallin and the b-Gal coding sequence cloned in the plasmid pGEMTEasy (Promega, Charbonnieres, France) were transferred to pShuttle after a Kpn1/BglII digestion to obtain gD-crystallinb-gal-polyA. The DNA corresponding to the MIP promoter was a generous gift of Xia Yan Wang (Bethesda, USA). The plasmid was digested by Xho1 and HindIII. The promoter fragment was inserted in pShuttle b-gal-polyA to generate pShuttle MIPb-gal-polyA.
The DNA clone for Filensin was a generous gift of F Bounari (Harvard, USA). The DNA region containing the promoter was obtained by PCR amplification with the primers: 5 0 -GCTCTAGACGGTGCTGTCTCAGCCGATCA and 5 0 -CCAAGCTTCCGCGGCCTGGGCTGTGCC. The PCR fragment was digested with EcoRV and HindIII and inserted in pShuttle bgal-polyA to generate pShuttle Filensinb-gal-polyA. Replication-defective (DE1,E3) Ad vectors expressing b-Gal under the transcriptional control of CMV, aA-crystallin, gD-crystallin, LEP503, Filensin or MIP promoters were constructed with the AdEasy System (Qbiogen, France) as described previously. The recombinant adenoviruses were propagated in 293 cells, and purified by cesium chloride gradient. Viral titers were determined by optical absorbance at 260 nm (1 OD 260 ¼ 1 Â 10 12 physical particle/ml) and the viral particle DNA of each Ad vectors were sequenced.
To standardize the multiplicity of infection (MOI), 1 Â 10 5 cells were seeded in a six-well plate and the following day, one of the six wells was trypsinized and the cells were counted. Transductions were performed in 5% CO 2 incubators at 371C for 1 h using 500 ml of transduction medium (the same medium used for each cell line+2-% FCS) with agitation. Pilot experiments with AdCMVbgal were used to estimate the optimal MOI for rabbit lens epithelial (RLE) cells and rhexis.
Cell culture
A total of 293 cells were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA) and maintained as monolayers at 371C in a humidified 5% CO 2 atmosphere in DMEM medium supplemented with 10% FCS. Rabbit lens epithelial cells, obtained from rabbit capsular bag 6 were grown in Hank/F12 medium supplemented with 20% FCS.
X-Gal staining
Rabbit lens epithelial cells and tissues (corneas or capsular bag) tissues were transduced by adding the different Ad vectors (10 6 and 10 8 pfu, respectively). Forty-eight hours post-transduction, transduced cells or tissues were washed twice with PBS, fixed 5 min in 1% formaldehyde/0.1% glutaraldehyde/PBS washed twice again with PBS and finally stained with X-Gal (5-bromo-4-chloro-3-indoyl-b-D-galactoside; Life Technologies Inc., Cergy Pontoise, France).
Using a phase-contrast microscope, random fields were selected and examined at a magnification of X20. X-Gal positive cells, as well as total cells in the microscopic field were counted. This procedure was performed for three random fields in triplicate. Percentages of transduced cells were calculated.
Animals
The rabbits used in the study were between 2 and 3 months old. All the animals used in this study were cared for and treated in accordance with the ARVO statement for the use of animals in ophthalmic and vision research. Only one eye was treated in each animal.
Human tissues
Corneas and capsular bags were obtained from postmortem eyes. Donors were between the ages of 65 and 85 years.
Surgical procedure: phacoemulsification
Phacoemulsification was conducted as previously described. 8 Briefly, a small corneal incision was made at the limbus with a 3.2 mm blade. High viscosity sodium Hyaluronate (Healon GV) was then injected intracamerally. Then, a 3 mm round capsulorhexis leaving the anterior capsule relatively intact was performed. After hydrodissection of the lens, phacoemulsification was performed. No intraocular lens was implanted. The corneal incision was sutured with 10.0 nylon.
In vivo transduction with the viral vectors
Following phacoemulsification, we injected into the anterior chamber, with a 30 G needle, the different viral vector suspensions (100 ml containing 10 8 infectious vector particles).
Delivery using vector/biocompatible gel mixture AdCMVbgal was diluted in two different gels (containing 10% Trypan blue) at a final dose of 10 10 pfu. We initially used Matrigel (BD Biosciences), which is liquid at 41C and solidifies quickly at room temperature. Suspension of the viral vectors in sodium Hyaluronate (Healon) was more difficult due to the viscoelastic properties of Healon, which was used at concentrations of 1% or less. For both gels, experiments were initially performed in vitro on RLE cells to determine if the viral vector could be release from the gels and the optimal time of contact. In vivo experiments in rabbits consisted in filling at the end of the phacoemulsification the empty Lens-specific expression for gene therapy of PCO F Malecaze et al capsular bag with the gels to keep the vector in direct contact with the remaining lens cells. The gel was aspirated after 10 min to remove any excess viral vector or any foreign material.
Abbreviations
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